In the last half-decade, research has made significant advancements in breast cancer treatment. Although it remains the most common cancer diagnosis for Canadian women, the five-year survival rate for breast cancer patients is nearly 87 per cent. But not everything is so rosy. In nearly 30 per cent of patients, breast cancer tumours return after five years, significantly decreasing survival. Join our expert panel as they discuss the past 50 years of biological research and current efforts at the University of Manitoba to develop new ways of detecting breast cancer and new treatments for fighting recurrent breast cancer tumours and improving patient quality of life.

Dr. Marshall Pitz
Medical Oncologist, Director of Clinical Research, Research Institute of Hematology and Oncology, a joint institute of the University of Manitoba and CancerCare Manitoba

Dr. Sabine Hombach-Klonisch
Associate Professor, Section Head Gross Anatomy, Department of Human Anatomy and Cell Science, University of Manitoba, Member of the Manitoba Breast Cancer Research Group, Member of the Brain Tumor Research Alliance of Manitoba (BTRAM)